Florida News

World

Pressure Mounts on Lord Mandelson to Resign from House of Lords Amid Deepening Epstein Scandal Fallout

Former UK ambassador to Washington, Peter Mandelson, faces intensifying political and public pressure to relinquish his lifetime seat in the House of Lords following new revelations about his financial and personal ties to the late convicted sex offender Jeffrey Epstein. Prime Minister Keir Starmer has called for his resignation, as documents suggest payments and close correspondence between the two.

Feb 2, 2026

US

Appeals Court Rejects DOJ Misconduct Complaint Against Federal Judge, Citing Lack of Evidence

A federal appeals court has dismissed a Justice Department misconduct complaint against U.S. District Judge James Boasberg, ruling the government failed to substantiate its allegations regarding the judge's public comments.

Feb 2, 2026

Business

Aptiv Gains Analyst Favor as Strategic Shift Yields 'More Realistic' Growth Outlook

Aptiv PLC sees mixed but upwardly revised price targets from major analysts, with Piper Sandler upgrading the auto tech supplier to Overweight and naming it a top pick for 2026, citing its pragmatic strategy and attractive valuation.

Feb 2, 2026

Business

Analysts Bullish on Ardelyx Ahead of Q4 Earnings, Citing Blockbuster Potential for Key Drug

Ardelyx, Inc. (NASDAQ: ARDX) has received significant analyst upgrades, with TD Cowen and Jefferies raising price targets ahead of the company's fourth-quarter results. The optimism centers on the commercial trajectory of its flagship drug, tenapanor, for gastrointestinal and kidney conditions.

Feb 2, 2026

Business

Taysha Gene Therapies Gains Momentum as Wells Fargo Raises Target on Rett Syndrome Program

Wells Fargo boosts its price target for Taysha Gene Therapies (TSHA), citing strong progress in its pivotal Rett syndrome gene therapy program. The company has dosed the first patient in a key trial phase and received FDA alignment on its regulatory pathway.

Feb 2, 2026

Business

Janux Therapeutics Downgraded as Key Drug Data Gaps Raise Platform Concerns

Clear Street downgrades Janux Therapeutics (JANX) to Hold, slashing its price target amid concerns over a lack of durability data for its lead candidate JANX007 and rising competitive pressures, despite a recent major collaboration deal with Bristol Myers Squibb.

Feb 2, 2026

Business

Goldman Sachs Downgrades MoonLake to Sell, Citing Trial Setback and Regulatory Hurdles

Goldman Sachs has downgraded MoonLake Immunotherapeutics (MLTX) to Sell, highlighting the failed VELA-2 trial endpoint and persistent approval risks for its key drug, sonelokimab, despite a competing firm's more bullish outlook.

Feb 2, 2026

Business

Apis Flagship Fund Outperforms in Q4 2025, Cites Stock Picks and Strategy

The Apis Flagship Fund reported robust quarterly and annual gains for 2025, significantly beating global benchmarks. While highlighting its performance drivers, the fund's investor letter also discussed its position on gene therapy firm uniQure (QURE).

Feb 2, 2026

US

Ohio Teen's Disappearance Linked to Online Gaming Contact; 39-Year-Old Man Arrested on Evidence Charges

Seventeen-year-old Hailey Buzbee vanished after leaving her Vermillion home in early January. Authorities now believe she is deceased and have arrested a man she met through online gaming, though murder charges have not yet been filed.

Feb 2, 2026

Business

U.S. Launches $12 Billion 'Project Vault' to Counter China's Rare Earth Dominance

The White House has confirmed the launch of a major strategic initiative to stockpile rare earth elements, aiming to reduce American dependence on China for the critical minerals used in defense tech and consumer electronics.

Feb 2, 2026

Business

Fortinet Upgraded to Buy as Analysts See Strong Q4 Tailwinds from Tax Breaks and Sales Execution

Rosenblatt Securities raised its rating on cybersecurity firm Fortinet ahead of its Q4 earnings, citing a favorable hardware refresh cycle, effective sales strategies, and supportive tax incentives as key growth drivers.

Feb 2, 2026

Business

Investors Pull Record $1.73B From Crypto Funds as Rate Cut Hopes Fade

Digital asset investment products witnessed their largest weekly capital flight since late 2025, with Bitcoin and Ethereum bearing the brunt of a $1.73 billion exodus. The sell-off, concentrated in the U.S., underscores a sharp pivot in risk appetite amid shifting macroeconomic winds, though Solana and select regions bucked the trend with modest inflows.

Feb 2, 2026

Business

Oracle Bets Big on AI Cloud Future with $50 Billion Fundraising Drive

Oracle is launching a massive $45-$50 billion capital raise to aggressively expand its cloud infrastructure, fueled by long-term contracts with AI giants like OpenAI, NVIDIA, and Meta. The move underscores the fierce competition in the cloud arms race, even as the company's stock faces recent headwinds.

Feb 2, 2026

Business

LGI Homes Bets on Solar and Upgrades with New California Community Launch

Homebuilder LGI Homes is testing a higher-specification housing model with the launch of its Monte Vista community in Modesto, California. The new single-story homes come with significant included upgrades and integrated solar energy systems, signaling a strategic shift towards energy efficiency and long-term cost-conscious buyers.

Feb 2, 2026

Business

Palantir's AI Software Growth Exceeds 25% Annually, Phillip Securities Sees Major Upside with $208 Target

Phillip Securities initiates coverage of Palantir Technologies with a Buy rating, citing its AI software segment's robust growth and significant market expansion potential. A new partnership with Innodata aims to enhance Palantir's rodeo analysis platforms through advanced data services.

Feb 2, 2026

Business

Uber's Valuation Faces Near-Term Pressure Amid Autonomous Vehicle Uncertainty, BofA Says

BofA Securities has trimmed its price target for Uber Technologies, citing near-term uncertainties in the autonomous vehicle sector, even as the company launches a new internal data initiative aimed at accelerating AV development.

Feb 2, 2026

Business

GigaWatt Seeks Public Backing to Power Its DIY Solar Ambitions as Energy Costs Soar

Amid rising electricity prices and shifting federal incentives, solar platform GigaWatt is turning to crowd-investing to accelerate its push into integrated, user-friendly DIY solar kits, betting on AI and streamlined hardware to capture a growing market.

Feb 2, 2026

Business

Twist Bioscience Powers Ahead: Q1 2026 Revenue Jumps 17%, Fueled by AI-Driven Discovery Boom

Twist Bioscience kicks off fiscal 2026 with robust growth, reporting a 17% year-over-year revenue increase to $103.7 million. The company credits its semiconductor-based DNA synthesis platform and surging demand from AI-enabled drug discovery programs as key drivers, while reiterating its path to adjusted EBITDA breakeven within the year.

Feb 2, 2026

Business

Zions Bancorporation Greenlights $75M Share Buyback, Signaling Confidence Amid Sector Scrutiny

Zions Bancorporation has authorized a new $75 million stock repurchase program, a move analysts see as a bet on its undervalued shares and a commitment to shareholder returns as regional banks navigate a cautious regulatory environment.

Feb 2, 2026

Business

Major Banks Pledge to Match Federal 'Baby Bond' Contributions for Employees' Children

JPMorgan Chase, Bank of America, and Wells Fargo announce plans to match a $1,000 government deposit into retirement accounts for children of eligible employees, part of a new national savings initiative.

Feb 2, 2026